Screener
ArriVent BioPharma, Inc. AVBP Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by ArriVent BioPharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The source filing: ArriVent BioPharma, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 4:08 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-058650
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Short-term investments | 264,277 | 267,281 |
| Prepaid expenses and other current assets | 22,320 | 20,076 |
| Total current assets | 348,700 | 332,897 |
| Right of use assets – operating leases | 370 | 13 |
| Deferred offering costs | 69 | 69 |
| Other assets | 156 | 190 |
| Total assets | $349,295 | $333,169 |
| Liabilities and Stockholders’ Equity |
Item 1. Condensed Financial Statements (Unaudited):
FAQ
- What is ArriVent BioPharma, Inc.'s operating lease ROU assets?
- ArriVent BioPharma, Inc. (AVBP) reported operating lease ROU assets of $370K in Q1 2026.
- How has ArriVent BioPharma, Inc.'s operating lease ROU assets changed year-over-year?
- ArriVent BioPharma, Inc.'s operating lease ROU assets increased by 208.3% year-over-year, from $120K to $370K.
- What is the long-term trend for ArriVent BioPharma, Inc.'s operating lease ROU assets?
- Over 2 years (2023 to 2025), ArriVent BioPharma, Inc.'s operating lease ROU assets has grown at a -78.9% compound annual growth rate (CAGR), from $291K to $13K.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about ArriVent BioPharma, Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude